Abstract
Up-regulation of the hepatocyte growth factor (HGF), its transmembrane tyrosine kinase receptor (c-Met), and urokinase type plasminogen activator (uPA), is associated with the development and metastasis of various types of cancers. However, the mechanisms by which HGF/c-Met signaling mediates cancer progression and metastasis are unclear. We investigated the roles of HGF/c-Met in tumor progression and metastasis in NUGC-3 and MKN-28 stomach cancer cell lines. Treatment with HGF increased c-Met phosphorylation in a dose-dependent manner, as well as increasing cell proliferation. HGF treatment also increased the protein level and the activity of uPA in NUGC-3 and MKN-28 cells. A monoclonal antibody against human uPA receptor (uPAR), mAb 3936, inhibited HGF-mediated tumor cell invasion in a dose-dependent manner. Down-regulation of uPA using uPA-shRNA induced a decrease in in vitro cell invasion in NUGC-3 cells. These results suggest that NUGC-3 and MKN-28 cells express functional c-Met, which may provide a therapeutic target for interfering with metastases of cancer cells by inhibiting uPA and uPAR-mediated proteolysis.
References
Jan 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G K Michalopoulos, R Zarnegav
Feb 15, 1991·Science·D P BottaroS A Aaronson
Aug 1, 1989·The Journal of Cell Biology·J F CajotB Sordat
May 1, 1989·The Journal of Cell Biology·R W StephensA Vaheri
Aug 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M P StoppelliR K Assoian
Aug 1, 1988·Molecular and Cellular Biology·S GiordanoP M Comoglio
Nov 30, 1987·FEBS Letters·T NakamuraT Nishino
Nov 1, 1988·Clinical & Experimental Metastasis·S R HarveyG Markus
Sep 6, 1984·Nature·C S CooperG F Vande Woude
Sep 4, 1995·Cancer Letters·M JohnsonA Iyer
Aug 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M M HeissF W Schildberg
Dec 23, 1993·Biochimica Et Biophysica Acta·J S RubinS A Aaronson
Mar 1, 1996·Molecular and Cellular Biology·M JeffersG F Vande Woude
Jan 1, 1997·British Journal of Cancer·D CanteroM W Büchler
Jun 29, 2000·Oncogene·K GiehlP Gierschik
Jun 16, 2001·Carcinogenesis·S KermorgantT Lehy
Jun 26, 2004·Oncology·Kyung Hee LeeHee Sun Kim
Jun 1, 2003·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Kyung Hee LeeJae Ryong Kim
Citations
Nov 10, 2007·Clinical & Experimental Metastasis·Kyung Hee LeeJae-Ryong Kim
Jun 19, 2012·Cancer Biotherapy & Radiopharmaceuticals·Ying-Yu Ma, Hou-Quan Tao
Jan 21, 2010·The Journal of Pharmacology and Experimental Therapeutics·B J YamamotoJ W Harding
May 6, 2011·Cancer Biology & Therapy·Daniel V T CatenacciRavi Salgia
Sep 30, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Shuang LiYi Ba
Mar 15, 2014·Oncology Reports·Kyung Hee LeeJae-Ryong Kim
Jun 19, 2010·Molecular and Cellular Biochemistry·Kyung Hee LeeJae-Ryong Kim